Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors
Sarina A. Piha-Paul,Christine L. Hann,Christopher A. French,Sophie Cousin,Irene Brana, Phillippe A. Cassier,Victor Moreno,Johann S. de Bono, Sara Duckworth Harward,Geraldine Ferron-Brady,Olena Barbash,Anastasia Wyce,Yuehui Wu,Thierry Horner, Meg Annan,Nigel J. Parr,Rabinder K. Prinjha,Christopher L. Carpenter,John Hilton,David S. Hong,Naomi B. Haas,Mark C. Markowski,Arindam Dhar,Peter J. O'Dwyer,Geoffrey Shapiro JNCI Cancer Spectrum（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper